National Institutes of Health Awards Grant to Immunetics for More Accurate Lyme Disease Test
Cambridge, MAโฆApril 3, 2002โฆImmunetics, Inc. was awarded a Phase I SBIR admission by the National Institute of Allergy and Communicable Diseases, a analysis of the National Institutes of Health, to abutment a analytic balloon allegory of its new Lyme ache analysis with the two-tier agreement currently acclimated for Lyme diagnosis. Immunetics’ analysis was accustomed endure year by the FDA for use as a first-tier screening test. This is the aboriginal Lyme ache analysis to accomplish use of a peptide antigen termed โC6โ, which screens out apocryphal absolute after-effects accepted to added tests for Lyme disease. Earlier analytic trials accept apparent the C6 peptide to be a awful acute and specific brand for acknowledgment to B. burgdorferi, the spirochetal abettor of Lyme disease, in both U.S. and European patients. The C6 analysis aswell eliminates apocryphal absolute after-effects which may be due to added altitude or to anesthetic with Lymerixยฎ, the vaccine from GlaxoSmithKline.
Immunetics will accompany armament with advisers at Tulane University and added bookish institutions beneath the new grant. In the analytic trial, the acuteness of the C6 Lyme analysis will be abstinent in groups of animal patients followed over time, and in nonhuman primates which serve as an beginning archetypal for animal Lyme disease.
โWe accept already approved the superb acuteness and specificity of the C6 analysis as a aboriginal bank screening testโ said Dr. Andrew Levin, Immunetics’ architect and Chief Executive Officer. โOur ambition in this anxiously controlled study, using a accumulation of the world’s a lot of well-characterized specimens from Lyme ache patients and abbey subjects, is to actuate whether the C6 analysis can alter the accepted two-tier agreement – a aggregate of screening and acknowledging testing for Lyme ache which is a time-consuming, big-ticket and still amiss approach. We accept that patients and bloom affliction practitioners will account from a individual analysis that is added accurate, amount effective, faster and simpler than the two bank method. We ahead that the after-effects of the abstraction which is now underway will absolutely abutment the abeyant of the C6 analysis to supercede this method. We are actual admiring and accustomed that the National Institute of Allergy and Communicable Diseases has called to abutment this cogent analytic balloon which represents a key footfall on that path, and additionally to accept the befalling to coact on this admission with our colleagues at Tulane University and added arch Lyme ache analysis centers, acknowledgment to whom the abstraction specimens will be accessible to us.โ
The C6 ELISA kit is accessible in the U.S. anon from Immunetics. Physicians can locate the abutting class alms the C6 analysis by calling Immunetics at 800-227-4765.
Immunetics offers advanced appraisal technology for communicable ache analysis and diagnosis, and for over ten years has been a arch innovator of tests for Lyme and added tick-borne diseases. The aggregation produces and markets a ambit of communicable ache immunoassay kits and instruments.
Author: Anonymous
Source: free-articles
Posted in Other